4//SEC Filing
Laponis Adam 4
Accession 0001214659-26-000423
CIK 0001581280other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:05 PM ET
Size
5.2 KB
Accession
0001214659-26-000423
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1]2026-01-09$35.26/sh−2,738$96,545→ 140,031 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis|2026-01-13
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001827198
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:05 PM ET
- Size
- 5.2 KB